Valerian: No evidence for Clinically Relevant interactions

被引:0
|
作者
Kelber, O. [1 ,2 ]
Nieber, K. [1 ,3 ]
Kraft, K. [1 ,4 ]
机构
[1] Working Grp Efficacy Safety & Interact Kooperat P, D-53173 Bonn, Germany
[2] Steigerwald Arzneimittelwerk GmbH, Dept Sci, D-64295 Darmstadt, Germany
[3] Univ Leipzig, Inst Pharm, D-04103 Leipzig, Germany
[4] Univ Med Rostock, Chair Complementary Med, Ctr Internal Med, D-18057 Rostock, Germany
关键词
D O I
暂无
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
引用
收藏
页码:1138 / 1139
页数:2
相关论文
共 50 条
  • [21] Clinically relevant drug interactions of current antifungal agents
    Gubbins, Paul O.
    Heldenbrand, Seth
    MYCOSES, 2010, 53 (02) : 95 - 113
  • [22] Drug-Drug Interactions: Theoretical or Clinically Relevant?
    Martha, Gabriella
    Doro, Peter
    Benko, Ria
    Higyisan, Ilona
    Matuz, Maria
    Soos, Gyongyver
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S42 - S42
  • [23] Mechanisms of Clinically Relevant Drug Interactions Associated with Tacrolimus
    Uwe Christians
    Wolfgang Jacobsen
    Leslie Z. Benet
    Alfonso Lampen
    Clinical Pharmacokinetics, 2002, 41 : 813 - 851
  • [24] Clinically relevant drug interactions; it's time for education
    Verbeek, R.
    Richir, M.
    Tichelaar, J.
    van Agtmael, M.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 75 : S45 - S45
  • [25] Mechanisms of clinically relevant drug interactions associated with tacrolimus
    Christians, U
    Jacobsen, W
    Benet, LZ
    Lampen, A
    CLINICAL PHARMACOKINETICS, 2002, 41 (11) : 813 - 851
  • [26] CYTOSTATIC DRUGS AND DIETARY SUPPLEMENTS - CLINICALLY RELEVANT INTERACTIONS?
    Farkouh, A.
    Georgopoulos, A.
    Czejka, M.
    ANTICANCER RESEARCH, 2014, 34 (10) : 5900 - 5901
  • [27] Evidence of Clinically Relevant Efficacy for Dietary Supplements and Nutraceuticals
    Cicero, Arrigo F. G.
    Borghi, Claudio
    CURRENT HYPERTENSION REPORTS, 2013, 15 (03) : 260 - 267
  • [28] Evidence of Clinically Relevant Efficacy for Dietary Supplements and Nutraceuticals
    Arrigo F. G. Cicero
    Claudio Borghi
    Current Hypertension Reports, 2013, 15 : 260 - 267
  • [29] Moxifloxacin and warfarin: Additional evidence for a clinically relevant interaction
    Arnold, LM
    Nissen, LR
    Ng, TMH
    PHARMACOTHERAPY, 2005, 25 (06): : 904 - 907
  • [30] Clinically Relevant Drug-Drug Interactions in Primary Care
    Carpenter, Mary
    Berry, Holly
    Pelletier, Allen L.
    AMERICAN FAMILY PHYSICIAN, 2019, 99 (09) : 558 - 564